Literature DB >> 19195055

Hepcidin modulation in human diseases: from research to clinic.

Alberto Piperno1, Raffaella Mariani, Paola Trombini, Domenico Girelli.   

Abstract

By modulating hepcidin production, an organism controls intestinal iron absorption, iron uptake and mobilization from stores to meet body iron need. In recent years there has been important advancement in our knowledge of hepcidin regulation that also has implications for understanding the physiopathology of some human disorders. Since the discovery of hepcidin and the demonstration of its pivotal role in iron homeostasis, there has been a substantial interest in developing a reliable assay of the hormone in biological fluids. Measurement of hepcidin in biological fluids can improve our understanding of iron diseases and be a useful tool for diagnosis and clinical management of these disorders. We reviewed the literature and our own research on hepcidin to give an updated status of the situation in this rapidly evolving field.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19195055      PMCID: PMC2653344          DOI: 10.3748/wjg.15.538

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  117 in total

1.  Novel urine hepcidin assay by mass spectrometry.

Authors:  Erwin Kemna; Harold Tjalsma; Coby Laarakkers; Elizabeta Nemeth; Hans Willems; Dorine Swinkels
Journal:  Blood       Date:  2005-07-19       Impact factor: 22.113

Review 2.  Cellular iron: ferroportin is the only way out.

Authors:  Tomas Ganz
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

3.  Iron absorption by healthy women is not associated with either serum or urinary prohepcidin.

Authors:  Kevin B Hadley; LuAnn K Johnson; Janet R Hunt
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

4.  The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.

Authors:  J A Lebrón; A P West; P J Bjorkman
Journal:  J Mol Biol       Date:  1999-11-19       Impact factor: 5.469

5.  The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney.

Authors:  H Kulaksiz; F Theilig; S Bachmann; S G Gehrke; D Rost; A Janetzko; Y Cetin; W Stremmel
Journal:  J Endocrinol       Date:  2005-02       Impact factor: 4.286

6.  Hepcidin in iron overload disorders.

Authors:  George Papanikolaou; Michalis Tzilianos; John I Christakis; Dionisios Bogdanos; Konstantina Tsimirika; Julie MacFarlane; Y Paul Goldberg; Nikos Sakellaropoulos; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

7.  Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Authors:  Raffaella Origa; Renzo Galanello; Tomas Ganz; Nicolina Giagu; Liliana Maccioni; Gavino Faa; Elizabeta Nemeth
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

Review 8.  Hemochromatosis: an endocrine liver disease.

Authors:  Antonello Pietrangelo
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

9.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

10.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

View more
  32 in total

1.  Serum hepcidin: a novel diagnostic tool in disorders of iron metabolism.

Authors:  Gaetano Bergamaschi; Laura Villani
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

2.  Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome.

Authors:  Paola Trombini; Valentina Paolini; Sara Pelucchi; Raffaella Mariani; Elizabeta Nemeth; Tomas Ganz; Alberto Piperno
Journal:  Liver Int       Date:  2011-04-18       Impact factor: 5.828

3.  Splenectomy improves anaemia but does not reduce iron burden in patients with haemoglobin H Constant Spring disease.

Authors:  Ya-Li Zhou; Xin-Hua Zhang; Tie-Niu Liu; Li Wang; Xiao-Lin Yin
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

4.  Influence of post-exercise hypoxic exposure on hepcidin response in athletes.

Authors:  Claire E Badenhorst; Brian Dawson; Carmel Goodman; Marc Sim; Gregory R Cox; Christopher J Gore; Harold Tjalsma; Dorine W Swinkels; Peter Peeling
Journal:  Eur J Appl Physiol       Date:  2014-02-01       Impact factor: 3.078

5.  The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS).

Authors:  Lynda Addo; Katsuya Ikuta; Hiroki Tanaka; Yasumichi Toki; Mayumi Hatayama; Masayo Yamamoto; Satoshi Ito; Motohiro Shindo; Yusuke Sasaki; Yasushi Shimonaka; Mikihiro Fujiya; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2016-01       Impact factor: 2.490

Review 6.  Impact of chronic and acute inflammation on extra- and intracellular iron homeostasis.

Authors:  A Catharine Ross
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 7.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

8.  Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.

Authors:  Natascia Campostrini; Annalisa Castagna; Federica Zaninotto; Valeria Bedogna; Nicola Tessitore; Albino Poli; Nicola Martinelli; Antonio Lupo; Oliviero Olivieri; Domenico Girelli
Journal:  J Biomed Biotechnol       Date:  2010-04-15

9.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11

10.  Decreased serum prohepcidin concentration in patients with polycythemia vera.

Authors:  Justyna Kwapisz; Ewa Zekanowska; Joanna Jasiniewska
Journal:  J Zhejiang Univ Sci B       Date:  2009-11       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.